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This is a short collection of interesting items pertinent to 
medicine and science in general. It gives a taste of some 
of the current work in hand around the world. We would 
welcome any contributions of this nature, just a short 
chatty narrative of an interesting or amusing article that 
you have seen or read.
 Breast Results ? 
Edinburgh was one of the centres entered in 
the UK Trial of the Early Detection of Breast 
Cancer (TEDBC), the seven year mortality 
results of this huge trial have just been pub­
lished (Lancet 1990; 335:241-6).
The main objective of this trial is to compare 
the mortality from breast cancer in areas in 
which screening was offered to that in other 
areas. Unfortunately the results after seven 
years are inconclusive, since the reduction in 
mortality(17%) is too small to be significant 
This statistic includes in the study population 
all those women who were invited to attend 
a clinic for screening; only 61% attended 
initially and this number fell each year (to as 
low as 47.6% in 60-64 age group). This ab­
solutely apalling attendance should be com­
pared to Sweden where the response rate 
from women was 74%.
It is now extremely rare there for any women 
to present with advanced and inoperable 
disease in comparison to this country in 
which 35% of women fall into this category. 
Surely vast improvements are desperately 
needed in education, without this any full 
scale screening programme would be a vast, 
expensive disaster. It will however be
several years before the final effects of this 
trial are measurable since the detection rate 
for cancer in the screened population was 
higher than in controls; hopefully a reflec­
tion of earlier detections in screened women. 
Perhaps it is still possible for some positive 
result to emerge from this extensive trial.
Just a Nibble...
On a slightly lighter note, a fascinating re­
port on ‘Traumatic Love Bites” (BrJ.Surg. 
1990, vol 77,100-101) discusses some un­
usual problems! Given the choice, my 
advice to the reader would be to be bitten by 
a dog in preference; while dogs mouth’s are 
normally sterile, the range of potential infec­
tions following human bites includes alpha- 
haemolytic streptococci and Bacteroides 
species.
Seven cases are reported, including a young 
man who presented with a bleeding neck. 
Although the bleeding itself was trivial the 
bite marks were deep enough to traumatise 
the external jugular vein. A second example 
was of a man with a supraclavicular, hard, 
non-tender mass with a central hole. On 
excision a broken plastic tooth was removed, 
this was later found to have originated from 
a love bite by a lady dressed as a vampire at 
a Halloween party a year previously!
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Phaging Phat 
The understanding of the aetiology of ath­
erosclerosis has spawned a bewildering ar­
ray of theories but no single causative 
method yet mooted has held much water on 
its own merit.
Two papers in Nature (1, 2) may have 
changed that A group in Massachusetts 
have been working on scavenger receptors 
on macrophages found in atherosclerotic 
plaques which may lead to their accumula­
tion of low density lipoprotein (LDL) from 
the blood. The receptors detect a change in 
the charge of LDL caused by the acetylation 
of lysine moieties on the particle, this effect 
is also mimicked by the oxidation of the 
complex constituents of LDL. Result the 
macrophages chomp up these altered blood 
components and become chubby little foam 
cells.
Trouble is that the oxidised lipoproteins 
might cause these corpulent corpuscles to 
release polypeptides to stimulate a local tis­
sue reaction that is not best contained in the 
cramped confinement of an artery wall. 
That is just the start of the trouble... What is 
more, oxidised LDL seems to accumulate 
and transfer lysolecithin, an amphiphile, to 
arterial endothelial cells producing a selec­
tive unresponsiveness to endothelium de­
pendant vasoregulatory stimuli in vitro (3) 
this closely equates to the vasoregulatory 
impairment observed in atherosclerotic ves­
sels. Anyway, guess what can best oxidise 
LDL in the blood, yup, you gottit, cigarette 
smoke. Down the cancer stix guys.
1. Kodaraa, T. et al. Nature 343,531-535 (1990)
2. Rohrer, L. et aL Nature 343,570-572 (1990)
3. Kugiyama, K. et al  Nature 344,160-162 (1990)
 Heated topic 
Well, I’m doing anaesthetics at the moment 
and have just been told about malignant 
hyperthermia, a potentially lethal condition 
which can be triggered by anaesthetics (or 
caffeine, ooerr!) in some individuals. It has 
an autosomal recessive or codominant in­
heritance and the condition gives rise to a 
sustained contraction of striated muscle 
chewing up masses of ATP and evolving 
lots of unwanted kiloJoules. Result the bod 
is cooked, and it tends to ruin the 
anaesthetist’s usually unfettered day with a 
dead patient. Testing up to now has been by 
muscle biopsy, impractical in large num­
bers, but now there is the hope of a recombi­
nant DNA technique to indicate susceptibil­
ity (1). The gene locus responsible has been 
localised to chromosome 19q12-13.2, quite 
a big chunk below the centromere, sdll it is a 
good start. Better still one group has found 
that the gene for susceptibility is snuggled 
up to a gene for a calcium ion release chan­
nel, perhaps even the two are the same. 
Sounds sort of positive to me, they also 
confirm that the gene that they are looking 
at is on chromosome 19, more specifically 
in the q13.1 band (2). Check it out
1. MacLennan, D.H. et a l Nature 343,559-561 (1990)
2. McCarthy, T.V, et al. Nature 343,562-563 (1990)
 Blue Genes 
There is work afoot to perform human gene 
therapy in the US for children with the fan­
tastically rare severe combined immunode­
ficiency who lack the gene for a deaminase 
which normally mops up toxins that destroy 
the immune system. Solution; readminister 
T-lymphocytes, the sort nobbled by HTV, 
that have been genetically repaired with the 
correct gene and then souped up with a
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course of Interleukin-2 which gets them into 
a fighting fit state. The therapy may fail, 
give a temporary or even a lasting effect 
We will never know if the Recombinant 
DNA Advisory Committee of the National 
Institutes of Health gives the trial the 
thumbs down. Peel your peepers.
1. Gershon, D. Nature (News) 344,2 (1990)
Cold Comfort 
Sniffling? 50% of colds are caused by rhi- 
noviruses which enter cells via an interac­
tion with a cell membrane bound receptor 
called Inter-Cellular Adhesion Molecule-1 
(innovative eh?) or ICAM-1. A US group 
has chopped the intra-membrane and intra­
cellular moiety off ICAM-1 and found that 
the sICAM-1 (soluble) will inhibit the cyto- 
pathic effects of rhinoviruses but not other 
viruses.
Wait though, the stuff has to be proved in 
vivo and then the problems of sensitivity to 
the new protein may cause anaphylaxis 
(immediate severe allergy, may be life 
threatening) or more sinister, may provoke 
an autoimmune response. Best is that it is a 
novel approach to the production of antivi­
ral drugs that up till now have concentrated 
on koshing the bug after it has got into the 
cell.
1. Marlin, S.D. et al. Nature 344,70-72 (1990)
Trial tried
Trials for a new drug to combat HIV have 
taken on a new guise in St. Mary’s Hospital 
in London. The drug is dideoxyinosine 
(ddl) which inhibits reverse transcriptase, 
and, to date shows no advantage over AZT, 
the current drug therapy for AIDS victims. 
The trial is novel in that it allows patients to
choose whether they may have placebo or 
not, this overcomes fears that drug trials 
may withhold therapy from some patients. 
Option A is a standard randomisation into 
placebo, low dose and high dose ddl groups, 
Option B just excludes the placebo group. 
Some patients are already booked into op­
tion A.
1. Aldhous, P. Nature 344,95 (1990)
Chili chomping 
A letter to Nature mentioned that research in 
remote areas can be hampered by animals 
chewing cables and equipment In Britain 
the critters would probably be shot, poi­
soned or electofrazzled, however workers in 
Alaska devised a more subtle and devious 
ploy. They sprinkled ‘Tabasco’ sauce onto 
the installations, lo and behold no more 
technochomping, it seems that wildlife is 
incapable of the ‘hedonic shift’ present in 
crazy humans who gulp gallons of the con­
centrated nerve poison.
1. Nelson, F.E. Nature 344,115-116 (1990)
 Blood Feud
Interesting things have been happening in 
New York with regard to patient rights. A 
Jehovah’s Witness was given a blood trans­
fusion against her wishes after a massive 
post-partum haemorrhage on the basis that 
her child would be harmed through being 
deprived of her care. S’prise, s’prise, she 
took it to court and won the right not to have 
had a transfusion in that other family mem­
bers have been deprived of the opportunity 
to show that they could have cared for the 
child should the woman have died. Con­
fused? I think they all are. It is now an 
absolute ‘right’ in New York to refuse a 
blood tranfusion.
1. Charatan, F. BMJ 300,491-492 (1990)
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Whiter than White? 
It seems that some of the ecoconcem of the 
modem world is tripping over itself rather. 
Modern washing methods are energy-con­
scious, low temperature and environment- 
friendly, low tripolyphosphate. All well 
and good, but the wily Italians have shown 
that our sox and undies et al. can develop the 
most tenacious collections of organic gunge 
on a microscopic level. What the eye can­
not see etc. But the bugs and greublies don’t 
care, it is their first foothold to gnashing the 
fibres and jumping onto warm and moist 
bodies. The main problem is to get an ade­
quate detergency to scoop the gloop and 
reduce the bug farm on your wardrobe with­
out turning the rivers into algae holiday 
homes and stagnating lakes.
1. Dixon, B. BMJ 300,528-529, (1900)
Choleconfusion 
I was just in the States (gloat) and I noted an 
intense interest to reduce salt and choles­
terol intake and stuff as much bran in as 
could fit. That’s OK, but it was pathologi­
cal in some parts of the country, ‘You can 
tay’ll when th’yrall from California ‘cos 
th’yall ask for caffeine-free herbal tea and 
vegetable flakes.’, quote from New Orleans 
waiter. Well studies show that lowering 
cholesterol intake has a minimal effect on 
blood cholesterol levels and that high bran 
diets, or low fibre wheat supplements for 
that matter, lower cholesterol concentration 
by the same amount, simply by the fact that 
the subjects reduced their intake of choles­
terol and fat while on the supplements. 
What can we do. The old story...sensible 
eating, less saturated fat an more fibre. Cut 
the overkill folks.
1. McBride, G. BMJ 300,560 (1990)
Coffee Crisis 
Well it is certain that high blood cholesterol 
correlates with a raised risk of coronary 
heart disease, it is now becoming certain 
that coffee consumption has a relationship 
with raised plasma cholesterol concentra­
tions, and more...
A recent study has examined death from 
coronary heart disease and related this to 
coffee consumption (1). There is a clear 
correlation, but worse than that the effect 
due to coffee seems to be a little, but signifi­
cant, bit more than the cholesterol raising 
effect alone.
So, while I remonstrate over the rim of my 
cup about cigarette smoking, I am now left 
with the potential consequences of my own 
vice of >9 cups of treacle like coffee a day. I 
must move onto tea. I have one theory why 
Scandinavians drink so much coffee, its 
because they make such awful tea. Igno­
rance! you might say, but how would you 
like tea made in a filter coffee machine?
I said there was more...Another group is 
suggesting a link between parental coffee 
consumption and the genesis of insulin de­
pendant diabetes mellitus (2) some demon 
drink this!!
1.Tverdal, A. BMJ 300,566-569 (1990)
2. Tuomilehto, J. BMJ 300,642-643 (1990)
Ilf you have a contribution for 
Journalscan send it to the 
RMS office for the next issue 
addressed to the Editors, 
Res Medica and see your 
name in print.
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